155 related articles for article (PubMed ID: 35516602)
1. Preparation of quercetin-nicotinamide cocrystals and their evaluation under
Wu N; Zhang Y; Ren J; Zeng A; Liu J
RSC Adv; 2020 Jun; 10(37):21852-21859. PubMed ID: 35516602
[TBL] [Abstract][Full Text] [Related]
2. Cocrystals of quercetin with improved solubility and oral bioavailability.
Smith AJ; Kavuru P; Wojtas L; Zaworotko MJ; Shytle RD
Mol Pharm; 2011 Oct; 8(5):1867-76. PubMed ID: 21846121
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Characterization, and Stability Optimization of Ibuprofen Cocrystals eEploying Various Hydrophilic Polymers.
Hassan A; Khan JA; Nasir F; Shabir H; Hannan PA; Ullah R; Jan A; Khalid A; Khan A; Al-Harrasi A
Curr Pharm Des; 2024 Jun; ():. PubMed ID: 38867533
[TBL] [Abstract][Full Text] [Related]
4. Chrysin cocrystals: Characterization and evaluation.
Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
[TBL] [Abstract][Full Text] [Related]
5. Effect of stoichiometry upon the characteristics of quercetin-arginine cocrystals formulated through solution crystallization.
Mishra M; Agrawal S; Bahadur P; Tiwari S
Drug Dev Ind Pharm; 2024 Feb; 50(2):163-172. PubMed ID: 38226968
[TBL] [Abstract][Full Text] [Related]
6. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.
Chow SF; Chen M; Shi L; Chow AH; Sun CC
Pharm Res; 2012 Jul; 29(7):1854-65. PubMed ID: 22359146
[TBL] [Abstract][Full Text] [Related]
7. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein.
Pi J; Wang S; Li W; Kebebe D; Zhang Y; Zhang B; Qi D; Guo P; Li N; Liu Z
Asian J Pharm Sci; 2019 Mar; 14(2):154-164. PubMed ID: 32104447
[TBL] [Abstract][Full Text] [Related]
8. Superior Solubility and Dissolution of Zaltoprofen via Pharmaceutical Cocrystals.
Panzade P; Shendarkar G
Turk J Pharm Sci; 2019 Sep; 16(3):310-316. PubMed ID: 32454729
[TBL] [Abstract][Full Text] [Related]
9. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs.
Meng Y; Tan F; Yao J; Cui Y; Feng Y; Li Z; Wang Y; Yang Y; Gong W; Yang M; Kong X; Gao C
Int J Pharm X; 2022 Dec; 4():100119. PubMed ID: 35663355
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
12. Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.
Al-Kazemi R; Al-Basarah Y; Nada A
Adv Pharm Bull; 2019 Oct; 9(4):559-570. PubMed ID: 31857959
[No Abstract] [Full Text] [Related]
13. Preparation, Characterization, in-vitro and in-vivo Pharmacokinetic Evaluation of Thermostable Dimethyl Fumarate Cocrystals.
Alam Q; Ganeshpurkar A; Singh SK; Krishnamurthy S
J Pharm Sci; 2024 Mar; 113(3):647-658. PubMed ID: 37595751
[TBL] [Abstract][Full Text] [Related]
14. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.
Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y
Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Dissolution Rate and Antibacterial Efficiency of Azithromycin through Drug-Drug Cocrystals with Paracetamol.
Ul Islam N; Khan E; Naveed Umar M; Shah A; Zahoor M; Ullah R; Bari A
Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34438989
[TBL] [Abstract][Full Text] [Related]
17. Cocrystal Construction Between Rosuvastatin Calcium and L-asparagine with Enhanced Solubility and Dissolution Rate.
Vemuri VD; Lankalapalli S
Turk J Pharm Sci; 2021 Dec; 18(6):790-798. PubMed ID: 34979738
[TBL] [Abstract][Full Text] [Related]
18. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
Kumar S; Gupta A; Prasad R; Singh S
Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-telmisartan polymeric cocrystals for improving oral absorption: In vitro and in vivo evaluation.
Ganesh M; Ubaidulla U; Rathnam G; Jang HT
Int J Biol Macromol; 2019 Jun; 131():879-885. PubMed ID: 30905757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
